United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24201-002_563fecaf-128d-4f6b-81c8-715b4d90a261
- Product NDC
- 24201-002
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LEVOTHYROXINE SODIUM
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20221115
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 100 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (24201-002-01) / 2 mL in 1 VIAL, SINGLE-DOSE · 24201-002-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →